Menu Search
Equities

Renalytix PLC

RNLXY:QBB

Renalytix PLC

Actions
  • Price (USD)0.1609
  • Today's Change0.006 / 3.77%
  • Shares traded78.20k
  • 1 Year change-68.44%
  • Beta2.7269
Data delayed at least 15 minutes, as of Nov 22 2024 20:58 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Cash flow in USDView more

In 2024, cash reserves at Renalytix PLC fell by 20.00m. Cash Flow from Financing totalled 10.25m or 447.79% of revenues. In addition the company used 30.11m for operations while cash used for investing totalled 4.00k.
Cash flow per share-0.6188
Price/Cash flow per share--
Book value per share-0.1018
Tangible book value per share-0.1018
More ▼

Balance sheet in USDView more

Renalytix PLC appears to have a weak balance sheet, highlighted by its negative owner's equity. Additionally, this company's debt load is greater than its assets while day-to-day operations are losing money. Renalytix PLC has considerable financial risk.
Current ratio0.5322
Quick ratio--
Total debt/total equity--
Total debt/total capital13.35
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.